Osteopontin deficiency impairs wear debris-induced osteolysis via regulation of cytokine secretion from murine macrophages

Arthritis and Rheumatism

Volumn 62, Issue 5, 2010, Pages 1329-1337

  Shimizu, Sadanori ^a   Okuda, Naoki ^a   Kato, Norihiko ^a   Rittling, Susan R ^b,c   Okawa, Atsushi ^a   Shinomiya, Kenichi ^a   Muneta, Takeshi ^a   Denhardt, David T ^c   Noda, Masaki ^a   Tsuji, Kunikazu ^a   Asou, Yoshinori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b FORSYTH INSTITUTE   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTACTIC FACTOR; CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; OSTEOPONTIN; TITANIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALVARIA; FEMALE; GENOTYPE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION;

ANIMALS; CELLS, CULTURED; CHEMOKINE CCL3; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; I-KAPPA B PROTEINS; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OSTEOLYSIS; OSTEOPONTIN; PHAGOCYTOSIS; SKULL; TITANIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951743716     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27400     Document Type: Article

References (47)

1. Harris WH. Wear and periprosthetic osteolysis: the problem. Clin Orthop Relat Res 2001;393:66-70.
2. Jacobs JJ, Roebuck KA, Archibeck M, Hallab NJ, Glant TT. Osteolysis: basic science. Clin Orthop Relat Res 2001;393:71-77
3. Willert HG. Reactions of the articular capsule to wear products of artificial joint prostheses. J Biomed Mater Res 1977;11:157-164
4. Green TR, Fisher J, Stone M, Wroblewski BM, Ingham E. Polyethylene particles of a 'critical size' are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 1998;19:2297-2302
5. Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM. Effect of anti-tumor necrosis factor-α gene therapy on wear debris-induced osteolysis. J Bone Joint Surg Am 2001;83-A:1789-1797
6. Nakashima Y, Sun DH, Trindade MC, Chun LE, Song Y, Goodman SB, et al. Induction of macrophage C-C chemokine expression by titanium alloy and bone cement particles. J Bone Joint Surg Br 1999;81:155-162 (Pubitemid 29043430)
7. Shanbhag AS, Hasselman CT, Rubash HE. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop Relat Res 1997;344:33-43.
8. Granchi D, Verri E, Ciapetti G, Stea S, Savarino L, Sudanese A, et al. Bone-resorbing cytokines in serum of patients with aseptic loosening of hip prostheses. J Bone Joint Surg Br 1998;80:912-917 (Pubitemid 28457091)
9. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000;289:1504-1508
10. Childs LM, Paschalis EP, Xing L, Dougall WC, Anderson D, Boskey AL, et al. In vivo RANK signaling blockade using the receptor activator of NF-κB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res 2002;17:192-199
11. Granchi D, Amato I, Battistelli L, Ciapetti G, Pagani S, Avnet S, et al. Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles. Biomaterials 2005;26:2371-2379 (Pubitemid 39600690)
12. Denhardt DT, Noda M. Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl 1998;30/31:92-102. (Pubitemid 29028730)
13. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001;107:1055-1061 (Pubitemid 32422899)
14. Asou Y, Rittling SR, Yoshitake H, Tsuji K, Shinomiya K, Nifuji A, et al. Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology 2001;142:1325-1332 (Pubitemid 32202845)
15. Saeki Y, Mima T, Ishii T, Ogata A, Kobayashi H, Ohshima S, et al. Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications. Br J Haematol 2003;123:263-270
16. Standal T, Hjorth-Hansen H, Rasmussen T, Dahl IM, Lenhoff S, Brenne AT, et al. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica 2004;89:174-182 (Pubitemid 38796491)
17. Zreiqat H, Kumar RK, Markovic B, Zicat B, Howlett CR. Macrophages at the skeletal tissue-device interface of loosened prosthetic devices express bone-related genes and their products. J Biomed Mater Res A 2003;65:109-117 (Pubitemid 37517291)
18. Yoshitake H, Rittling SR, Denhardt DT, Noda M. Osteopontindeficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci U S A 1999;96:8156-8160 (Pubitemid 29328424)
19. Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, et al. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci U S A 2002;99:4556-4561 (Pubitemid 34286023)
20. Rittling SR, Denhardt DT. Osteopontin function in pathology: lessons from osteopontin-deficient mice. Exp Nephrol 1999;7:103-113
21. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, et al. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 1998;13:1101-1111 (Pubitemid 28311778)
22. Schwarz EM, Benz EB, Lu AP, Goater JJ, Mollano AV, Rosier RN, et al. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res 2000;18:849-855
23. Goodman SB, Huie P, Song Y, Schurman D, Maloney W, Woolson S, et al. Cellular profile and cytokine production at prosthetic interfaces: study of tissues retrieved from revised hip and knee replacements. J Bone Joint Surg Br 1998;80:531-539 (Pubitemid 128472140)
24. Goodman SB, Trindade M, Ma T, Genovese M, Smith RL. Pharmacologic modulation of periprosthetic osteolysis. Clin Orthop Relat Res 2005;430:39-45.
25. O'Regan A, Berman JS. Osteopontin: a key cytokine in cellmediated and granulomatous inflammation. Int J Exp Pathol 2000;81:373-390 (Pubitemid 32291179)
26. Merkel KD, Erdmann JM, McHugh KP, Abu-Amer Y, Ross FP, Teitelbaum SL. Tumor necrosis factor-α mediates orthopedic implant osteolysis. Am J Pathol 1999;154:203-210 (Pubitemid 29031627)
27. Chellaiah MA, Soga N, Swanson S, McAllister S, Alvarez U, Wang D, et al. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem 2000;275:11993-12002 (Pubitemid 30237772)
28. Kanehisa J, Heersche JN. Osteoclastic bone resorption: in vitro analysis of the rate of resorption and migration of individual osteoclasts. Bone 1988;9:73-79
29. Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CA, et al. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol 2000;184:118-130 (Pubitemid 30349635)
30. Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, et al. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts. J Bone Miner Res 2002;17:1486-1497 (Pubitemid 34803832)
31. Caron E, Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998;282:1717-1721 (Pubitemid 28549289)
32. Chellaiah MA. Regulation of actin ring formation by rho GTPases in osteoclasts. J Biol Chem 2005;280:32930-32943
33. Blanchoin L, Amann KJ, Higgs HN, Marchand JB, Kaiser DA, Pollard TD. Direct observation of dendritic actin filament networks nucleated by Arp2/3 complex and WASP/Scar proteins. Nature 2000;404:1007-1011
34. Cox D, Chang P, Zhang Q, Reddy PG, Bokoch GM, Greenberg S. Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes. J Exp Med 1997;186:1487-1494 (Pubitemid 27479808)
35. Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J 1993;7:1475-1482
36. Patarca R, Saavedra RA, Cantor H. Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene. Crit Rev Immunol 1993;13:225-246 (Pubitemid 2030713)
37. Xu G, Nie H, Li N, Zheng W, Zhang D, Feng G, et al. Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 2005;115:1060-1067 (Pubitemid 40489411)
38. Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, et al. NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994;153:2052-2063 (Pubitemid 2138450)
39. Grove M, Plumb M. C/EBP, NF-κB, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1α immediate-early gene. Mol Cell Biol 1993;13:5276-5289
40. Von Knoch M, Jewison DE, Sibonga JD, Sprecher C, Morrey BF, Loer F, et al. The effectiveness of polyethylene versus titanium particles in inducing osteolysis in vivo. J Orthop Res 2004;22:237-243 (Pubitemid 38155277)
41. Kurtz SM, Muratoglu OK, Evans M, Edidin AA. Advances in the processing, sterilization, and crosslinking of ultra-high molecular weight polyethylene for total joint arthroplasty. Biomaterials 1999;20:1659-1688 (Pubitemid 29393122)
42. Ulrich-Vinther M, Carmody EE, Goater JJ, K Soballe, O'Keefe RJ, Schwarz EM. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am 2002;84-A:1405-1412 (Pubitemid 35407586)
43. Soloviev A, Schwarz EM, Darowish M, O'Keefe RJ. Sphingomyelinase mediates macrophage activation by titanium particles independent of phagocytosis: a role for free radicals, NFκB, and TNFα. J Orthop Res 2005;23:1258-1265 (Pubitemid 41554655)
44. Taki N, Tatro JM, Nalepka JL, Togawa D, Goldberg VM, Rimnac CM, et al. Polyethylene and titanium particles induce osteolysis by similar, lymphocyte-independent, mechanisms. J Orthop Res 2005;23:376-383 (Pubitemid 40287864)
45. Ragab AA, Van De Motter R, Lavish SA, Goldberg VM, Ninomiya JT, Carlin CR, et al. Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J Orthop Res 1999;17:803-809 (Pubitemid 30033279)
46. Tatro JM, Taki N, Islam AS, Goldberg VM, Rimnac CM, Doerschuk CM, et al. The balance between endotoxin accumulation and clearance during particle-induced osteolysis in murine calvaria. J Orthop Res 2007;25:361-369 (Pubitemid 46455907)
47. Taki N, Tatro JM, Lowe R, Goldberg VM, Greenfield EM. Comparison of the roles of IL-1, IL-6, and TNFα in cell culture and murine models of aseptic loosening. Bone 2007;40:1276-1283